|
1
|
Didkowska J, Wojciechowska U, Mańczuk M
and Łobaszewski J: Lung cancer epidemiology: Contemporary and
future challenges worldwide. Ann Transl Med. 4:1502016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nadel E, Truini A, Nakata A, Lin J, Reddy
RM, Change AC, Ramnath N, Gotoh N, Beer DG and Chen G: A novel
serum-4-microRNA signature for lung cancer detection. Sci Rep.
23:124642015. View Article : Google Scholar
|
|
3
|
Tarver T: American cancer society cancer
facts & figures 2014. Jour Consum Heal Intern. 16:366–367.
2012. View Article : Google Scholar
|
|
4
|
Nanavaty P, Alvarez MS and Alberts WM:
Lung cancer screening: Advantages, controversies, and applications.
Cancer Control. 21:9–14. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fortunato O, Boeri M, Moro M, Verri C,
Mensah M, Conte D, Calecal L, Roz L, Pastorino U and Sozzi G:
Mir-660 is downregulated in lung cancer patients and its
replacement inhibits lung tumorigenesis by targeting MDM2-p53
interaction. Cell Death Dis. 11:e15642014. View Article : Google Scholar
|
|
6
|
Huang J, Sun C, Wang S, He Q and Li D:
MicroRNA miR-10b inhibition reduces cell proliferation and promotes
apoptosis in non-small cell lung cancer (NSCLC) cells. Mol Biosyst.
11:2051–2059. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kent OA and Mendell JT: A small piece in
the cancer puzzle: microRNAs as a tumor suppressors and oncogenes.
Oncogene. 25:6199–6196. 2006. View Article : Google Scholar
|
|
8
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Imamura T, Komatsu S, Ichikawa D, Miyamae
M, Okajima W, Ohashi T, Kiuchi J, Nishibeppu K, Konishi H, Shiozaki
A, et al: Depleted tumor suppressor miR-107 in plasma relates to
tumor progression and is a novel therapeutic target in pancreatic
cancer. Sci Rep. 7:57082017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu P, Qi X, Bian C, Yang F, Lin X, Zhou
S, Xie C, Zhao X and Yi T: MicroRNA-18a inhibits ovarian cancer
growth via directly targeting TRIAP1 and IPMK. Oncol Lett.
13:4039–4046. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang JZ, Bian L, Hou JG and Wang HY:
MiR-550a-3p promotes non-small cell lung cancer cell proliferation
and metastasis through down-regulating TIMP2. Eur Rev Med Pharmacol
Sci. 22:4156–4165. 2018.PubMed/NCBI
|
|
12
|
Han L, Chen W, Xia Y, Song Y, Zhao Z,
Cheng H and Jiang T: MiR-101 inhibits the proliferation and
metastasis of lung cancer by targeting zinc finger E-box binding
homeobox 1. Am J Transl Res. 10:1172–1183. 2018.PubMed/NCBI
|
|
13
|
Cui J, Mo J, Luo M, Yu Q, Zhou S, Li T,
Zhang Y and Luo W: c-Myc-activated long non-coding RNA h19
downregulates miR-107 and promotes cell cycle progression of
non-small cell lung cancer. Int J Clin Exp Pathol. 8:12400–12409.
2015.PubMed/NCBI
|
|
14
|
Xia H, Li Y and Lv X: MicroRNA-107
inhibits tumor growth and metastasis by targeting the BDNF-mediated
PI3K/AKT pathway in human non-small lung cancer. Int J Oncol.
49:1325–1333. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takahashi Y, Forrest AR, Maeno E,
Hashimoto T, Daub CO and Yasuda J: MiR-107 and miR-185 can induce
cell cycle arrest in human non small cell lung cancer cell lines.
PLoS One. 4:e66772009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression (data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang JJ, Wang CY, Hua L, Yao KH, Chen JT
and Hu JH: MiR-107 promotes hepatocellular carcinoma cell
proliferation by targeting Axin2. Int J Clin Exp Pathol.
8:5168–5174. 2015.PubMed/NCBI
|
|
18
|
Zhang M, Wang X, Li W and Cui Y: MiR-107
and miR-25 simultaneously target LATS2 and regulate proliferation
and invasion of gastric adenocarcinoma (GAC) cells. Biochem Biophys
Res Commun. 460:806–812. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheng F, Yang Z, Huang F, Yin L, Yan G and
Gong G: MicroRNA-107 inhibits gastric cancer cell proliferation and
metastasis by targeting PI3K/AKT pathway. Microb Pathog.
121:110–114. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu M, Guo D, Cao Z, Xiao L and Wang G:
Inhibitory effect of microRNA-107 on osteosarcoma malignancy
through regulation of wnt/β catenin signaling in vitro. Cancer
Invest. 36:175–184. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang P, Liu X, Shao Y, Wang H, Liang C,
Han B and Ma Z: MicroRNA-107-5p suppresses non-small cell lung
cancer by directly targeting oncogene epidermal growth factor
receptor. Oncotarget. 8:57012–57023. 2017.PubMed/NCBI
|
|
22
|
Chen JF, Mandel EM, Thomson JM, Wu QL,
Callis T, Hammond SM, Conlon FL and Wang DZ: The role of microRNA-1
and microRNA-133 in skeletal muscle proliferation and
differentiation. Nat Genet. 38:228–233. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu P, Qi X, Bian C, Yang F, Lin X, Zhou
S, Xie C, Zhao X and Yi T: MicroRNA-18a inhibits ovarian cancer
growth via directly targeting TRIAP1 and IPMK. Oncol Lett.
13:4039–4046. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
He Q, Yang X, Ren X, Wen X, Zhang J, Wang
Y, Liu N and Ma J: Overexpression of mitochondria mediator gene
TRIAP1 by miR-320b loss is associated with progression in
nasopharyngeal carcinoma. PLoS Genet. 12:e10061832016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang B, Zuo ZJ, Lv F, Zhao L, Du MJ and
Gao YS: MiR-107 inhibits proliferation of lung cancer cells through
regulating TP53 regulated inhibitor of apoptosis 1 (TRIAP1). Open
Life Sci. 12:200–205. 2017.
|
|
26
|
Tian XP, Jin XH, Li M, Huang WJ, Xie D and
Zhang JX: The depletion of PinX1 involved in the tumorigenesis of
non-small cell lung cancer promotes cell proliferation via
p15/cyclin D1 pathway. Mol Cancer. 16:742017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Du B, Wang Z, Zhang X, Feng S, Wang G, He
J and Zhang B: MicroRNA-545 suppresses cell proliferation by
targeting cyclin D1 and CDK4 in lung cancer cells. PLoS One.
9:e880222014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Y, Chen T, Huang H, Jiang Y, Yang L,
Lin Z, He H, Liu T, Wu B, Chen J, et al: miR-363-3p inhibits tumor
growth by targeting PCNA in lung adenocarcinoma. Oncotarget.
8:20133–20144. 2017.PubMed/NCBI
|
|
29
|
Wang X, Shi W, Shi H, Lu S, Wang K, Sun C,
He J, Jin W, Lv X, Zhou H and Shu Y: TRIM11 overexpression promotes
proliferation, migration and invasion of lung cancer cells. J Exp
Clin Cancer Res. 35:1002016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xue Y, Wu L, Liu Y, Ma Y, Zhang L, Ma X,
Yang Y and Chen J: ENTPD5 induces apoptosis in lung cancer cells
via regulating caspase 3 expression. PLoS One. 10:e01200462015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gu JJ, Qiao KS, Sun P, Chen P and Li Q:
Study of EGCG induced apoptosis in lung cancer cells by inhibiting
PI3K/Akt signaling pathway. Eur Rev Med Pharmacol Sci.
22:4557–4563. 2018.PubMed/NCBI
|
|
32
|
Stegh AH: Targeting the p53 signaling
pathway in cancer therapy-the promises, challenges and perils.
Expert Opin Ther Targets. 16:67–82. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang ZC, Liu JX, Shao ZW, Pu FF, Wang BC,
Wu Q, Zhang YK, Zeng XL, Guo XD, Yang SH and He TC: In vitro effect
of microRNA-107 targeting Dkk-1 by regulation of Wnt/β-catenin
signaling pathway in osteosarcoma. Medicine (Baltimore).
96:e72452017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sirotkin AV, Laukova M, Ovcharenko D,
Brenaut P and Mlyncek M: Identification of microRNAs controlling
human ovarian cell proliferation and apoptosis. J Cell Physiol.
223:49–56. 2010.PubMed/NCBI
|
|
35
|
Yamakuchi M, Lotterman CD, Bao C, Hruban
RH, Karim B, Mendell JT, Huso D and Lowenstein CJ: P53-induced
microRNA-107 inhibits HIF-1 and tumor angiogenesis. Proc Natl Acad
Sci USA. 107:6334–6339. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Andrysil Z, Kim J, Tan AC and Espinosa JM:
A genetic screen identifies TCF3/ESA and TRIAP1 as pathway-specific
regulators of the cellular response to p53 activation. Cell Rep.
3:1346–1354. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu P, Qi X, Bian C, Yang F, Lin XJ, Zhou
S, Xie C, Zhao X and Yi T: MicroRNA-18a inhibits ovarian cancer
growth via directly targeting TRIAP1 and IPMK. Oncol Lett.
13:4039–4046. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhao J, Li X, Zou M, He J, Han Y, Wu D,
Yang H and Wu J: MiR-135a inhibition protects A549 cells from
LPS-induced apoptosis by targeting Bcl-2. Biochem Biophys Res
Commun. 452:951–957. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sun SY, Yue P, Zhou JY, Wang Y, Choi Kim
HR, Lotan R and Wu GS: Overexpression of BCL2 blocks TNF-related
apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung
cancer cells. Biochem Biophys Res Commun. 280:788–797. 2001.
View Article : Google Scholar : PubMed/NCBI
|
